Summary: Four different, well known colour reagents for iron determination were tested in a citrate buffer at pH 2.0 under the same automated standard conditions and compared with a manual reference method on human serum and plasma samples. Specific results were obtained only with the chromogen tripyridyl-striazine. A micromethod was developed, which is generally well suited for automated, direct serum iron determinations, with respect to good flow properties, simple reagent composition, high reagent stability, rapid colour development, stable colour complex and high specificity. This method was run on either a Gilford
and ferrozine. The latter chromogen has a somewhat higher molar absorptivity than tripyridyl-s-triazine and bathophenanthroline sulphonate. Later, ferene-S, a chromogen with improved molar absorptivity and the same features as ferrozine, with respect to slow colour development and interference by copper (10) , was introduced for serum iron determination (11) . The relatively slow colour development in the ferrozine reaction was found to be a limiting factor in some analysers (6) . Interference by copper can be eliminated with thiosemicarbazide, which forms an uncoloured complex with copper (10) . Reaction of thiosemicarbazide with ascorbic acid impairs reagent stability. If the test is not performed at sufficiently acidic pH, interference by released haemoglobin iron may arise (10) . Such difficulties may easily impair the specificity of the measurement, in particular in the clinically important, abnormally low range. We searched for an improved, automated method for serum iron determination, which overcomes these problems.
Materials and Methods

Chemicals
Bathophenanthroline suJphonate (4,7-diphenyl-l. 10-phenanthroline disulphonic acid sodium salt), TPTZ (2,4,6-tripyridyls-triazine), ferrozine (3-(2-pyridyl)-5,6-bis(4-phenylsulphonic acid)-l,2,4-triazine sodium salt) and ferene-S (3-(2-pyridyl)-5,6-bis(2-(5-furyl-sulphonic acid))-l ,3,4-triazine disodium salt) were from Sigma Chem. Corp., Duishofen, FRG. Other analytical grade reagents were obtained from E. Merck Darmstadt, FRG. The iron standard was either from Boehringer Mannheim, FRG (17.9 μιηοΐ/ΐ) or prepared from a stock solution, containing 895.5 μηιοΙ/1 iron. The stock solution was made by dissolving reduced iron in approx 6 mol/1 HC1, followed by dilution to 1 1 with distilled water.
Serum and plasma samples
Control sera were obtained from E. Merck, Darmstadt, FRG (Seronorm), from Beckman, Munich, FRG (Decision Level 1 -3) and from Behringwerke, Marburg, FRG (Kontrollogen-LP).
Serum or plasma samples from patients with normal and pathological iron values were used. Sampling was performed between 8 and 9 a. m. under fasting conditions. Tubes containing ammonium heparinate were used for obtaining plasma.
Instrumentation
In the present investigation, serum (plasma) iron and urine desferal iron determinations were performed either on a Gilford System 203 S, a Gilford Impact 400 Analyser (Gilford Instruments, Oberlin, OH, USA) or a Greiner G-400 analyser (Greiner Instruments GmbH, Birkenfeld, FRG). Only the tripyridyl-striazine method was adaptable to the Greiner G-400 (at 37 °C). Atomic absorption spectrophotometric determinations of iron in urine were performed on a Perkin-Elmer 2380 system (PerkinElmer Corp., Norwalk, Ct., USA).
Reagents
The reagent for sample blanks (reagent 1) consisted of 0.24 mol/1 aqueous citric acid monohydrate (50 g/1 + 1 drop of chloroform) and 5.6 mmol/1 ascorbic acid. The colour reagent (reagent 2) consisted of 1.6 mmol/l of one of the reagents, tripyridyl-s-triazme, bathophenanthroline sulphonate, ferrozine or ferene-S dissolved in reagent 1. Total-'bilirubin was measured on a Greiner G-40 with the dichloroaniline method (kit from Greiner No. 4057).
Method for serum (plasma) examinations
The methods were run with sample and reagent blanks at 25 °C on the Gilford Systems with four different standards (2.2, 4.5, 9.0 and 17.9 μτηοΐ/ΐ) and at 37 °C on the Greiner G-400 with or without standards. Details for the programming of these systems are listed in table 1. The measurements were performed at a wavelength of 593, 533, 562 and 593 nm with tripyridyl-striazine, bathophenanthroline sulphpnatej ferrozine and ferene-S, respectively. The tripyridyks-triazine/citrate method was found to be linear up to at least 260 μιηοΐ/l. For the examination of urine samples, higher standards were used (see below). The systems were accepted for use when they showed linearity for the different standards (automatically checked) and/or a withinrun precision of 2% or less in a control serum (Decision Level 2). Otherwise, a cleaning of the system with 0.1 rnol/I HC1 and/ or a photometer check (lamp drift) was performed, After an initial cleaning with HC1, problems of contamination normally do not occur in selective analysers such as the Greiner G-400 and comparable systems.
Tab. 1. Data on the programming of the Gilford systems and the Greiner G-400.
Gilford WAWELENGTH TRANSPORT TEMP. CUVETTE TEMP. SAMPLE VOLUME VOLUME DISP. A VOLUME DISP. B VOLUME DISP. C READ TIME EQUIL. TIME TIME A TO B TIME A TO C LAG TIME 
Pretreatment of urine samples
The urine samples were diluted 1:3.5 with a solution containing citric acid (0.57 mol/1) and ascorbic acid (0.48 mol/1); 0.5 ml of this diluted solution was placed in a capped micro reaction vessel and kept in a heat block (Eppendorf 3401, Eppendorf Ger tebau, Hamburg, FRG) at 56 °C for 15 min. After this pretreatment, the urine sample was assayed automatically as described above. If the total amount of ferrioxamine iron and transferrin iron in serum is to be determined, serum can be pretreated in the same manner. 
Results
Investigation of different chromogens
The reaction time for total colour development was found to be 30 s for tripyridyl-s-triazine, 2 min for bathophenanthroline sulphonate and ferrozine and l h for ferene-S, examined at 25 °C and at a pH of 1.85 (see tab. 2). The four different chromogens were tested under the same standard conditions, using 0.24 mol/1 citric acid/-HCl-NaOH buffer. Figure 1 indicates that tripyridyl-s-triazine has a constant colour intensity in the pH range between 1.6 and 4.0 and bathophenanthroline sulphonate in the pH range 1.3 to at least 6.0. The chromogens ferrozine and ferene-S were found to have a somewhat less constant colour intensity between pH 1.6 and 4.6 and between pH 1.7 and 4.6, respectively. All reagents were found to be stable for at least 2 months at 4 -8 °C and 1 week at room temperature. The colour complexes of tripyridyl-s-triazine and ference-S were found to be stable for at least 72 h, and for bathophenanthroline sulphonate and ferrozine for at least 36 and 24 h, respectively. The interference of copper in the tripyridyls-triazine/citrate method was found to be less than 2.0% in a plasma with various concentrations of added copper chloride, as described in detail elsewhere (13) .
Correlations with the reference method Sixty different plasma samples from patients were tested with tripyridyl-s-triazine, bathophenanthroline sulphonate, ferrozine and ferene-S and the results compared with those from the reference method. In figure 2 a, it is shown that a good correlation was obtained with the tripyridyl-s-triazine method. No interference was observed in this method in icteric, lipaemic or haemolytic plasmas. These findings show clearly that the tripyridyl-s-triazine/citrate method is specific and sensitive for iron determination in human blood. This method detects iron concentrations of less than 0.2 μπιοΐ/ΐ. Distinctly turbid, lipaemic sera may impair precision and should be pretreated with a commonly available cleaning agent. Interference with the determination of haemoglobin iron arise at 37 °C on the Greiner system in plasmas with a haemoglobin content of 0.8 g/1 or more. In the other systems, haemoglobin contents up to 5.0 g/1 did not interfere, as demonstrated in table 3. In figure 2 it is shown that the other chromogens have a considerably positive error, particularly in the pathologically decreased range, as also demonstrated in table 4. In plasmas with iron concentrations above 10.2 μιηοΐ/ΐ the correlation with the reference method was found to be improved, and the difference between the 4 different chromogens was found to be almost balanced. Two plasma samples with elevated total bilirubin concentration were found to have a falsely positive error in the bathophenanthroline sulphonate/citrate method at pH 2.0. These plasma samples (fig. 2b * and **) had bilirubin concentrations of 73.5 and 278.3 μήΐοΐ/ΐ, respectively, indicating that bilirubin interferes with this method. The latter finding was confirmed in a pooled plasma from 12 different icteric patients. In this pooled plasma, the following data were obtained: total bilirubin = 155.6 μιηοΐ/ΐ, iron concentration in the tripyridyl-s-triazine method = 17.6 μιηοΐ/ΐ, iron concentration in the bathophenanthroline sulphonate method == 24.7 μιηοΐ/l, positive error in the batho- phenanthroline sulphonate method = 40.3%. By increasing (decreased plasma/reagent ratio) the pH in the direct bathophenanthroline sulphonate method from pH 2.0 to pH 4.0, the interference by bilirubin was abolished. Thus, the bathophenanthroline sulphonate/citrate method seems to be specific for iron measurement at the latter pH. No significant difference in the iron concentration could be detected between human serum and plasma. 
Accuracy and precision in control sera
The best precision in the tripyridyl-s-triazine method was obtained in non-lyophilized sera with a CV ranging from 0.72 to 1.11% (within one run), as shown in table 5. The day-to-day variation and mean accuracy for Seronorm were 2.4% and + 0.5%, respectively.
Adaptation to other automated systems The tripyridyl-s-triazine/citrate method was adapted to a Technicon SMAC II and Technicon RA 1000 (13) , Eppendorf Epos and Abbot Spectrum automated analysers. The method can be run at any commonly used temperature. In the latter two systems, some modifications are necessary Ferrioxamine iron in urine
In order to release all desferal-bound iron during sample pretreatment at 56 °C, different molarities of citric acid and ascorbic acid were investigated. At 0.57 mol/1 citric acid and 0.48 mol/1 ascorbic acid, all ferrioxamine-bound iron was released for the tripyridyl-s-triazine reaction, as determined in urines with known ferrioxamine iron content. This pretreatment can also be used for serum samples, if both ferrioxamine iron and transferrin iron are to be determined.
') Data on the programming of the Eppendorf Epos and Abbott Spectrum systems are available from the author.
The correlation data between the tripyridyl-s-triazine method and the atomic absorption method in urine samples is demonstrated in figure 3 . These findings are in accordance to the data obtained in iron-free urine samples after addition of desferal and iron (II) chloride at various concentrationsr(not shown).
Discussion
The present investigation clearly shows that our tripyridyl-s-triazine/citrate method is specific and sensitive for direct iron measurements in human blood, and even in plasmas with iron values of 0.2 μιηοΐ/ΐ or less. The high specificity of tripyridyl-Sr-triazine is consistent with an earlier report (14) . Moreover, the simple reagent composition, high reagent stability and the instant colour development in the tripyridyl-striazine method are features of great practical importance, which facilitate an adaptation to other automated systems. It has previously been pointed out that tripyridyl-s-triazine, in contrast to ferrozine, is quite insoluble in water (14--15) . This seems to be the main reason why tripyridyl-s-triazine has found only limited use. Under our standard conditions, at an acidic pH, tripyridyl-s-triazine was totally soluble within few minutes.
The reaction time of l h found with ferene-S is somewhat longer than reported by Eskelinen (11) . Colour development within approx. 2 min in the bathophen : anthroline sulphonate-and ferrozine methods and within approx. 30 s for tripyridyl-s-triazine is therefore an obvious advantage. In our automated systems, a relatively good precision was obtained with ferene-S, even after an incubation time of only 5 min. The high sensitivity of ferene-S is only of limited value under these conditions. On the other hand, a reaction time of more than 5 to 10 min limits the usef llness of a method in an automated system. The positive error in the ferrozine and ferene-S method indicates interference by copper, in accordance with an earlier report (11) . We have no explanation at present for the interference of bilirubin at pH 2.0 in the direct bathophenanthroline sulphonate/citrate method. In view of this interference, the bathophenanthroline sulphonate method is not suitable as a micromethod under our standard conditions. In contrast to bathophenanthroline sulphonate, tripyridyl-s-triazine is available at low cost.
Both the reducing and chelating effect of citric acid and the rapid release of iron from transferrin at the low pH are advantageous. The coloured ferroin complexes also seem to be stabilized in our method, giving a constant colour development hva relatively wide pH-range, in contrast to HCl-glycine-Tween buffer at the same pH (16) . By the use of less sensitive photometric equipment, the latter finding enables a decrease in the ratio, sample/reagent volume, and hence an increase in pH.
The wide linear range of the ferrioxamine iron determination in urine samples with a high iron content is advantageous. During desferal treatment, an increase in the serum iron concentration occurs (17) . Without pretreatment of the serum samples, our method will release some ferrioxamine iron. Since desferal partly binds transferrin iron (18) , a decrease in the serum transferrin iron during desferal treatment can be expected. The quantity of released ferrioxamine iron may vary widely under different standard conditions. Direct serum iron determinations during desferal therapy might thus be rather uncertain. In contrast to an earlier report (19) , we found no evidence for the sensitivity of tripyridyl-s-triazine to desferal under our standard conditions. Pretreatment of samples permits the determination of the total ferrioxamine iron and transferrin iron in serum.
